Crossmark

The 90% effective dose of intrathecal hyperbaric bupivacaine for Cesarean delivery under combined spinal–epidural anesthesia in parturients with super obesity: an up-down sequential allocation study

Crossref DOI link: https://doi.org/10.1007/s12630-024-02705-5

Published Online: 2024-03-04

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tan, Hon Sen

Fuller, Matthew E.

Barney, Emily Z.

Diomede, Olga I.

Landreth, Riley A.

Pham, Trung

Rubright, Samantha M.

Ernst, Liliane

Habib, Ashraf S. https://orcid.org/0000-0002-6980-1856
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03781388 at ClinicalTrials.gov

Documents that mention this clinical trial

The 90% effective dose of intrathecal hyperbaric bupivacaine for Cesarean delivery under combined spinal–epidural anesthesia in parturients with super obesity: an up-down sequential allocation study
https://doi.org/10.1007/s12630-024-02705-5
License Information

Text and Data Mining valid from 2024-03-04

Version of Record valid from 2024-03-04
More Information

Article History

Received: 25 July 2023

Revised: 4 October 2023

Accepted: 4 November 2023

First Online: 4 March 2024

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below